Source: International Congress 2016 – Sarcoidosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Inigo Ojanguren Arranz (Barcelona, Spain), Inigo Ojanguren Arranz, Ferran Morell, Ana Villar, Christian Romero, María Antonia Ramón, María Jesus Cruz, Xavier Muñoz. Mortality and survival predictor in chronic hypersensitivity pneumonitis. Eur Respir J 2016; 48: Suppl. 60, 833

Member's Comments

No comment yet.

Related content which might interest you: Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification? Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Risk factors for chronic pulmonary aspergillosis in a low prevalence country and their effect on survival Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2014 – IPF and surroundings Year: 2014 Rituximab for the treatment of chronic hypersensitivity pneumonitis Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Chronic hypersensitivity pneumonitis with familial history of interstitial lung disease Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Using the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2015 – IIPs: orphan Year: 2015 Chronic interstitial lung disease in children Source: Eur Respir Rev, 27 (147) 170100; 10.1183/16000617.0100-2017 Year: 2018 Chronic interstitial lung disease in children Source: International Congress 2017 – Paediatric year in review: update on paediatric pulmonology Year: 2017 Morality predictors in acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 6 Year: 2014 Interstitial lung disease caused by designer drugs Source: International Congress 2015 – A morphological view of chest pathology Year: 2015 Variation in mortality from interstitial lung disease by diagnosis Source: International Congress 2015 – IIPs: orphan Year: 2015 Desquamative interstitial pneumonia in a Danish cohort, treatment response and outcome Source: International Congress 2014 – ILDs 2 Year: 2014 Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Risk factors and treatment outcomes in patients with chronic pulmonary aspergillosis Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016 Clinical experience with nintedanib for the treatment of IPF in 80 cases Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 The prognostic factor in patients with myositis-associated interstitial lung disease Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Burden and impact of hospital-acquired infections in patients with chronic lung disease Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption Year: 2016 Primary pulmonary interstitial glycogenosis. Long term outcome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013